Many studies have demonstrated that FGF21 had insulin-like effects, which could function as an effective metabolic regulator of glucose and lipid homeostasis in the context of insulin resistance, glucose intolerance, and dyslipidemia [4–6, 25, 26]. This evidence concerns the gene FGF21 and Insulin resistance.